Eli Lilly’s Mounjaro three times more effective than Ozempic for weight loss, real-world study finds

Eli Lilly’s Mounjaro is significantly more effective than Novo Nordisk’s Ozempic in producing weight loss in patients with overweight or obesity, a new real-world study found.

In an analysis of 18,000 patients, those taking Mounjaro were three times more likely than those taking Ozempic to achieve 15% weight loss, according to the study by Truveta Research, which analyzes de-identified patient data from a collective of health systems. After one year of treatment, the patients taking Mounjaro lost an average 15.2% of their…